Explore the latest advancements in prostate cancer management, focusing on survival data, treatment strategies, and patient care considerations.
Back
Advancing Clinical Perspectives in Prostate Cancer: Evidence, Outcomes, and Evolving Management Approaches
Experts review recent evidence shaping prostate cancer care, including emerging survival data, sion outcomes, and findings across biochemical recurrence and metastatic castration-sensitive prostate cancer. Experts discuss practical management considerations, including patient selection for monotherapy, long term tolerability, fatigue management strategies, and the role of exercise in supporting patients on therapy.
Advancing Clinical Perspectives in Prostate Cancer: Evidence, Outcomes, and Evolving Management Approaches
Episodes
All
All
Explore the latest advancements in prostate cancer management, focusing on survival data, treatment strategies, and patient care considerations.
Dr. Graham discusses the EMBARK study's findings on treatment suspension strategies for high-risk biochemical recurrence, highlighting survival benefits and future implications.
Explore the complexities of treatment interruption and resumption in prostate cancer therapy, including patient counseling and PSA monitoring strategies.
Dr. Graham discusses the impact of long-term survival data on treatment strategies for metastatic hormone-sensitive prostate cancer, emphasizing patient-specific approaches.
Recent ARCH trial data reveals significant survival benefits of enzalutamide combined with ADT for metastatic hormone-sensitive prostate cancer patients.
Recent ARCH trial data reveals significant survival benefits of enzalutamide combined with ADT for metastatic hormone-sensitive prostate cancer patients.
Recent ARCH trial data reveals significant survival benefits of enzalutamide combined with ADT for metastatic hormone-sensitive prostate cancer patients.
Healthcare professionals assess and manage fatigue in prostate cancer patients by evaluating severity, identifying reversible causes, and adjusting treatments for better quality of life.
Structured exercise plays a vital role in managing fatigue and improving overall health for patients, especially those undergoing cancer treatment.
Explore the evolving landscape of monotherapy for high-risk biochemical recurrence, focusing on patient selection and treatment outcomes.
Healthcare professionals navigate complex treatment options for high-risk biochemical recurrence, emphasizing patient preferences and quality of life in decision-making.
Clinicians emphasize the importance of personalized treatment strategies in metastatic hormone-sensitive cancer, considering patient-specific factors and trial insights.
Clinicians explore the limitations of cross-trial comparisons in treatment efficacy, emphasizing the need for randomized evidence over MAIC insights.
Clinicians explore the limitations of cross-trial comparisons in treatment efficacy, emphasizing the need for randomized evidence over MAIC insights.
Advertisement
Advertisement
Trending on OncLive
1
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
2
Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma
3
The OncFive: Top Oncology Articles for the Week of 8/16
4
ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC
5